115 related articles for article (PubMed ID: 38729325)
1. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J
Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325
[TBL] [Abstract][Full Text] [Related]
2. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
6. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
7. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
8. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
Xu Z; Wang Y; Xiong J; Cui F; Wang L; Peng H
J Cell Physiol; 2020 Apr; 235(4):3886-3893. PubMed ID: 31603257
[TBL] [Abstract][Full Text] [Related]
9. ING3 inhibits the malignant progression of lung adenocarcinoma by negatively regulating ITGB4 expression to inactivate Src/FAK signaling.
Cheng S; Li M; Zheng W; Li C; Hao Z; Dai Y; Wang J; Zhuo J; Zhang L
Cell Signal; 2024 May; 117():111066. PubMed ID: 38281617
[TBL] [Abstract][Full Text] [Related]
10. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract][Full Text] [Related]
11. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
12. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
Wu L; Jie B
Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
[TBL] [Abstract][Full Text] [Related]
13. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway.
Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z
Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circCRIM1 suppresses lung adenocarcinoma cell migration, invasion, EMT, and glycolysis through regulating miR-125b-5p/BTG2 axis.
Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YA; Zhang YJ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3761-3774. PubMed ID: 32329853
[TBL] [Abstract][Full Text] [Related]
15. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
17. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
[TBL] [Abstract][Full Text] [Related]
18. Circ_100549 promotes tumor progression in lung adenocarcinoma through upregulation of BIRC6.
Chen F; Chen J; Yuan Y; Fang S; Xie J; Xu X; Yang Z; Jiang J
Histochem Cell Biol; 2024 Jun; 161(6):493-506. PubMed ID: 38613646
[TBL] [Abstract][Full Text] [Related]
19. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
[TBL] [Abstract][Full Text] [Related]
20. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
